GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 204 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2022. The put-call ratio across all filers is 1.05 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $40,263,000 | +228.2% | 591,232 | +54.0% | 0.02% | +200.0% |
| Q2 2022 | $12,267,000 | +13.5% | 383,959 | +23.0% | 0.01% | +33.3% |
| Q1 2022 | $10,809,000 | +4.1% | 312,043 | -12.0% | 0.01% | +20.0% |
| Q4 2021 | $10,379,000 | +424.7% | 354,590 | +356.8% | 0.01% | +400.0% |
| Q3 2021 | $1,978,000 | +41.2% | 77,623 | +94.1% | 0.00% | 0.0% |
| Q2 2021 | $1,401,000 | -90.7% | 40,000 | -89.2% | 0.00% | -90.9% |
| Q1 2021 | $15,096,000 | +3232.5% | 370,447 | +3438.2% | 0.01% | – |
| Q4 2020 | $453,000 | -98.6% | 10,470 | -98.2% | 0.00% | -100.0% |
| Q3 2020 | $31,372,000 | +52.4% | 568,941 | +74.4% | 0.04% | +34.5% |
| Q2 2020 | $20,590,000 | +5179.5% | 326,152 | +4173.5% | 0.03% | +2800.0% |
| Q1 2020 | $390,000 | -98.2% | 7,632 | -97.1% | 0.00% | -96.3% |
| Q4 2019 | $21,200,000 | +229.0% | 266,700 | +100.8% | 0.03% | +145.5% |
| Q3 2019 | $6,444,000 | -63.0% | 132,822 | -59.9% | 0.01% | -57.7% |
| Q2 2019 | $17,423,000 | +135.9% | 331,236 | +137.4% | 0.03% | +136.4% |
| Q1 2019 | $7,386,000 | -32.7% | 139,542 | -47.8% | 0.01% | -35.3% |
| Q4 2018 | $10,974,000 | -44.6% | 267,341 | -48.7% | 0.02% | -29.2% |
| Q3 2018 | $19,806,000 | -33.6% | 521,228 | -21.0% | 0.02% | -40.0% |
| Q2 2018 | $29,826,000 | +176.9% | 659,877 | +195.9% | 0.04% | +185.7% |
| Q1 2018 | $10,772,000 | -43.0% | 223,026 | -53.5% | 0.01% | -46.2% |
| Q4 2017 | $18,882,000 | +5692.0% | 479,838 | +4463.4% | 0.03% | – |
| Q3 2017 | $326,000 | -78.6% | 10,515 | -81.1% | 0.00% | -100.0% |
| Q2 2017 | $1,521,000 | -4.9% | 55,607 | +28.1% | 0.00% | 0.0% |
| Q1 2017 | $1,599,000 | -47.7% | 43,404 | -76.4% | 0.00% | -57.1% |
| Q2 2016 | $3,055,000 | +0.4% | 184,115 | +155.1% | 0.01% | +16.7% |
| Q3 2015 | $3,043,000 | – | 72,168 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |